Impact of dose reductions on efficacy outcome in heart transplant patients receiving enteric-coated mycophenolate sodium or mycophenolate mofetil at 12 months post-transplantation
Author:
Publisher
Wiley
Subject
Transplantation
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1399-0012.2008.00887.x/fullpdf
Reference21 articles.
1. A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators;Kobashigawa;Transplantation,1998
2. Review of major clinical trials with mycophenolate mofetil in cardiac transplantation;Kobashigawa;Transplantation,2005
3. Adverse gastrointestinal effects of mycophenolate mofetil: aetiology, incidence and management;Behrend;Drug Saf,2001
4. Mycophenolate mofetil in organ transplantation: focus on metabolism, safety and tolerability;Shipkova;Expert Opin Drug Metab Toxicol,2005
5. Gastrointestinal complications in heart transplant patients: MITOS Study;Díaz;Transplant Proc,2007
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Letermovir for cytomegalovirus prophylaxis in high‐risk heart transplant recipients;Clinical Transplantation;2022-10-26
2. Comparison of mid-term clinical outcome in heart transplantation patients using mycophenolate mofetil vs. enteric-coated mycophenolate sodium;Frontiers in Cardiovascular Medicine;2022-08-23
3. Temporal shifts in safety and efficacy profile of mycophenolate mofetil 2 g versus 3 g daily early after heart transplantation;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2022-08-18
4. Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and the International Society for Heart and Lung Transplantation;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2022-08
5. Mycophenolic Acid Synergizing with Lipopolysaccharide to Induce Interleukin-1β Release via Activation of Caspase-1;Chinese Medical Journal;2018-07-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3